XENE
Overvalued by 94.8% based on the discounted cash flow analysis.
Market cap | $3.04 Billion |
---|---|
Enterprise Value | $2.52 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-2.5 |
Beta | 0.64 |
Outstanding Shares | 75,468,883 |
Avg 30 Day Volume | 336,320 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -18.56 |
---|---|
PEG | -35.47 |
Price to Sales | - |
Price to Book Ratio | 4.98 |
Enterprise Value to Revenue | 19063.04 |
Enterprise Value to EBIT | -13.52 |
Enterprise Value to Net Income | -16 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.02 |
No data
No data